Prognosis
Pfizer-BioNTech Covid Shot Cleared for Adolescents in U.S.
- Move sets stage for immunizing middle, high-school students
- Dosing could begin in coming days after CDC advisory meeting
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Pfizer Inc. and BioNTech SE’s Covid-19 vaccine was cleared for use in younger teens in the U.S., paving the way for the mass vaccination of middle- and high-school students before the start of summer camps and the next school year.